CAMBRIDGE, Mass. (AP) _ Proteostasis Therapeutics Inc. (PTI) on Thursday reported a loss of $9.4 million in its fourth quarter.
On a per-share basis, the Cambridge, Massachusetts-based company said it had a loss of 38 cents.
The biopharmaceutical company posted revenue of $4.1 million in the period.
For the year, the company reported a loss of $37.2 million, or $2.06 per share. Revenue was reported as $8.4 million.
Proteostasis shares have decreased 11 percent since the beginning of the year. In the final minutes of trading on Thursday, shares hit $10.89, a climb of 15 percent in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PTI at https://www.zacks.com/ap/PTI
Keywords: Proteostasis Therapeutics, Earnings Report